International China Biopharmaceutical Symposium (ICBPS)
•• Vaccines, Antibodies and Gene Therapeutics ••
Development, Regulatory Approval, Production, Distribution - China and Worldwide
Meeting Objective: Introduce Western biotech firms and the regulatory communities, the Drug Regulators, to the Chinese Biopharmaceutical Industries. Learn each others’ capabilities and capacities for product development and manufacturing. Learn the technical, scientific, medical and legal aspects of the processes associated with research and development, drug discovery; and developing and bringing biopharmaceuticals and pharmaceuticals to market in China and in the West. These areas include standards, trade practices, case studies, and regulation, as well as distribution/networking, market development internal to and external from China for Chinese and non-Chinese product, bulk product, and an exploration of the benefits of stable supplies of APIs. Of particular emphasis will be papers and presentations from professionals who are in the regulatory agencies of each producing country or who are very familiar with the regulatory process and procedures from each region such as the US and the Americas, the EU, Middle East, Pacific Rim and Asian countries. Contributions of papers and posters from each area are solicited.